Showing 701-710 of 1093 results for "".
- AbbVie to Acquire Allerganhttps://modernaesthetics.com/news/abbvie-to-acquire-allergan/2471892/AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan i
- InMode Rolls Out AccuTite for Face and Bodyhttps://modernaesthetics.com/news/inmode-rolls-out-accutite-for-face-and-body/2471925/InMode Ltd. is introducing AccuTite, the smallest Radio-Frequency Assisted Lipolysis (RFAL) device for precision fat reduction or skin contraction in the face and body. With its sub-millimeter cannula, AccuTite enables focal RF contra
- BTL News: New Small Emsculpt Applicator Targets Arms, Thighs, Calveshttps://modernaesthetics.com/news/btl-news-new-small-emsculpt-applicator-targets-arms-thighs-calves/2471930/BTL is rolling out a small Emsculpt applicator to treat arms, thighs and calves at the annual meeting of the American Society for Laser Medicine and Surgery in Denver. Until now, there were only protocols for the abdominals and buttocks. In addition to launching the small applicat
- Sciton Introduces JOULE X at ASLMShttps://modernaesthetics.com/news/sciton-introduces-joule-x-at-aslms/2471929/Sciton Inc. unveiled JOULE X and other new offerings at the annual American Society for Laser Medicine and Surgery Meeting in Denver, Colorado. An upgrade to the JOULE platform, JOULE X is the company’s latest multi-device platform. It works
- Harper's Bazaar, NewBeauty Honor BTL HIFEM Deviceshttps://modernaesthetics.com/news/harpers-bazaar-newbeauty-honor-btl-hifem-devices/2471939/BTL has received two new accolades from NewBeauty and Harper's Bazaar
- FDA Green Light's Galderma's Restylane Lyft for Midface Injection Via Cannulahttps://modernaesthetics.com/news/fda-green-lights-galdermas-restylane-lyft-for-midface-injection-via-cannula/2471998/The U.S. Food and Drug Administration (FDA) has approved the use of Galderma’s Restylane Lyft with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. This approval is the
- xMedica Launches Aesthetics Conference Focused on Energy Based Treatments for Male and Female Sexual Wellnesshttps://modernaesthetics.com/news/xmedica-launches-aesthetics-conference-focused-on-energy-based-treatments-for-male-and-female-sexual-wellness/2472007/Medical education consortium xMedica LLC of Atlanta has developed a new educational initiative, "The Use of Energy-Based Devices for Improving Sexual Health." The overriding goal of this unique conference is to present factual data in a CME setting to address this new are
- New from Lumenis: SPLENDOR X Laser Hair Removal Solutionhttps://modernaesthetics.com/news/new-from-lumenis-splendor-x-laser-hair-removal-solution/2472011/Lumenis Ltd. has launched SPLENDOR X, the first solid state laser system equipped with the unique BLEND X technology for fast and effective hair removal and skin solutions. The technology was showcased for the first time at the 2018 American Society of Dermatological Surgery (ASDS) in Phoenix thi
- BAAPS Calls for Brazilian Butt Lift Banhttps://modernaesthetics.com/news/baaps-calls-for-brazilian-butt-lift-ban/2472016/Due to the serious risks associated with the Brazilian butt lift, the British Association of Aesthetic Plastic Surgeons (BAAPS) is calling for a ban on the popular procedure until more data can be collected. The procedure is known to have the highest death rate of all cosmetic surger
- Special Report: Behind Allergan's and Bonti's Headline-Making Dealhttps://modernaesthetics.com/news/special-report-behind-allergans-and-bontis-headline-making-deal/2472032/The race was on. After years of dormancy in the neuromodulator category, at least three novel toxins— Evolus’ DWP-450, Revance’s daxibotulinumtoxinA, and Bonti’s EB-001—were coming down the pike. Industry watchers were abuzz with predictions about which toxin